Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Immunocore Holdings plc IMCR

Healthcare Biotechnology
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. It also develops other programs for oncology, including tebentafusp that is in Phase 3 clinical trial to treat... see more

Current News (NDAQ:IMCR)

Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire 7 days ago

Immunocore to present at upcoming investor conferences

GlobeNewswire November 10, 2025

Immunocore presents Phase 1 data for hepatitis B candidate at AASLD's The Liver Meeting

GlobeNewswire November 7, 2025

Immunocore reports third quarter financial results and provides a business update

GlobeNewswire November 6, 2025

Immunocore to present at upcoming investor conferences

GlobeNewswire September 4, 2025

Immunocore reports second quarter financial results and provides a business update

GlobeNewswire August 7, 2025

Immunocore to report second quarter 2025 financial results and host call on August 7, 2025

GlobeNewswire July 31, 2025

Immunocore to present at the 2025 Jefferies Global Healthcare Conference

GlobeNewswire June 2, 2025

Immunocore reports first quarter financial results and provides a business update

GlobeNewswire May 7, 2025
View More News ››

Opinion & Analysis (NDAQ:IMCR)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:IMCR)

Be the first to post on this bullboard.

Coelacanth Energy Inc.

Coelacanth Energy Inc.

Coelacanth Energy Inc., an oil and natural gas company, engages in the acquisition, development, exploration, and production ...
View More »

Podcasts